Technology Perk http://technewsperk.com Mon, 14 Apr 2014 11:02:52 +0000 en-US hourly 1 http://wordpress.org/?v=3.8.2 Chinese Volatile Stock On Hit List- Trina Solar Limited (ADR) (NYSE:TSL), 58.com Inc (ADR) (NYSE:WUBA), Qihoo 360 Technology Co Ltd (NYSE:QIHU) http://technewsperk.com/chinese-volatile-stock-on-hit-list-trina-solar-limited-adr-nysetsl-58-com-inc-adr-nysewuba-qihoo-360-technology-co-ltd-nyseqihu/216/ http://technewsperk.com/chinese-volatile-stock-on-hit-list-trina-solar-limited-adr-nysetsl-58-com-inc-adr-nysewuba-qihoo-360-technology-co-ltd-nyseqihu/216/#comments Mon, 14 Apr 2014 11:02:52 +0000 http://technewsperk.com/?p=216 Trina Solar Limited (TSL) reported that its State Key Laboratory of PV Science and Technology has developed a new high-efficiency Honey Ultra solar module. Vice President of Trina Solar and Director of the State Key Lab of PV Science and Technology, Dr. Zhiqiang Feng stated that because an advanced research and development facility, their State Key Lab of PV Science and Technology facilitates them to execute on their commitment to the commercialization of new high-efficiency solar cells and highly reliable modules.

Trina Solar Limited (ADR) (NYSE:TSL) [Trend Analysis] after opening at $11.70 hit its intraday high price of $12.33 moreover then finished at $11.56 by shares plunged -3.83%.  At Wall Street for latest quarter, the consensus average estimates of street for the revenue are $475.62M, at the same time as 10 experts forecast $575.28M revenues for the next three months of 2014. As took noticed on the firm sales growth (year/est), it is calculated 82.80% in Current Qtr. and for next quarter was forecasted 30.50%.

Gets Free Inside Facts on (NYSE:TSL)

58.com Inc. (NYSE: WUBA) recently SEC filings disclosed that Tiger Global Investments has rose its stake in the Chinese online classified-ad firm. All told, Tiger Global surged its stake from just 300,000 shares to over 2.52M. The new position correspond to 6.5 percent of all outstanding shares. Fast increasing search operators Qihoo 360 (QIHU) and Sogou may be challenging sector heavyweight Baidu (NASDAQ:BIDU) in terms of market share, but they’re having far more difficulty finding an audience among advertisers that are the sector’s main revenue source.

58.com Inc (ADR) (NYSE:WUBA) [Trend Analysis] shares trading performance in last session was noticeable, stocks slumped -1.55% with market capitalization of $6.29 billion, as outstanding shares was $77.79M. The recommendation trends from street professionals are, stock rated at “buy” by one analyst, while 2 analysts rates as a “hold” security. While the noticeable thing is mean recommendation of this week that stands at 2.3, [(Strong Buy 1.0 - 5.0 (Sell)] as on contradiction to last week recommendation of 2.0, which denotes 0.3variation in recommendations.

Acts and Reacts in Analytic Report, Finds (NYSE:WUBA)

Qihoo 360 Technology Co. Ltd. (QIHU) recently declared that its flagship security solution, 360 Safeguard XP Shield, withstood 13 hours of incessant attacks during an organized hacker contest, at the same time as two other security systems from Tencent in addition to Cheetah Mobile (formerly Kingsoft Internet Software) were breached in less than two minutes.

Qihoo 360 Technology Co Ltd (NYSE:QIHU) [Trend Analysis] reported the plunged of -0.01% and closed at $87.00 with the total traded volume of $4.37 shares. Its market capitalization was $21.36B. The stock owned by the Financial Institutions was 22%. The company’s shares have slump -26.46% in last 30 days and +7.37% in previous three months, compared to an decrease of -25.35% and -0.50% in the S&P 500 during the respective periods.

What are Prospects of NYSE:QIHU, Find the Free Technical Analysis

]]>
http://technewsperk.com/chinese-volatile-stock-on-hit-list-trina-solar-limited-adr-nysetsl-58-com-inc-adr-nysewuba-qihoo-360-technology-co-ltd-nyseqihu/216/feed/ 0
How Biotechnology Stocks Becom Bearish- Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Keryx Biopharmaceuticals (NASDAQ:KERX), Novavax, Inc. (NASDAQ:NVAX) http://technewsperk.com/how-biotechnology-stocks-becom-bearish-ariad-pharmaceuticals-inc-nasdaqaria-keryx-biopharmaceuticals-nasdaqkerx-novavax-inc-nasdaqnvax/213/ http://technewsperk.com/how-biotechnology-stocks-becom-bearish-ariad-pharmaceuticals-inc-nasdaqaria-keryx-biopharmaceuticals-nasdaqkerx-novavax-inc-nasdaqnvax/213/#comments Mon, 14 Apr 2014 11:02:42 +0000 http://technewsperk.com/?p=213 ARIAD Pharmaceuticals, Inc. (ARIA) released the selection of Hugh M. Cole to the position of senior vice president and chief business officer. Mr. Cole will be dependable for worldwide business and corporate development, licensing in addition to strategic planning. He will release to ARIAD’s chairman and CEO, Harvey J. Berger, M.D.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) [Trend Analysis] lost -1.26%, closing the day at $7.14 in last regular trading. The firm has market capitalization of $1.33B. It has PEG Ratio (5 yr expected) of -0.17%, along the price over sales value of $31.04 for the most recent quarter. Corporation has the total of cash of $237.18M as compares to total debt of $9.10M for the most recent quarter with the current ratio of 3.39% for the most recent quarter.

Why Investors Show Confidence on (NASDAQ:ARIA)

Keryx Biopharmaceuticals, Inc. (KERX) reported that Phase 2 clinical results of Zerenex(TM) in non-dialysis dependent chronic kidney disease (NDD-CKD) patients by means of elevated serum phosphorus in addition to iron deficiency anemia has been selected as a Late Breaking oral presentation at the National Kidney Foundation 2014 Spring Clinical Meeting, taking place April 22-26, 2014 in Las Vegas, NV.

Shares of Keryx Biopharmaceuticals (NASDAQ:KERX) [Trend Analysis] decreased -3.06% to the trading at $14.26. The firm has 52-week low range of $6.61 and 52-week high price was $17.46. The recommendation trends from street professionals are, stock rated at “buy” by 6 analysts, while 4 analysts rates as a “strong buy” security. While the noticeable thing is mean recommendation of this week that stands at 1.6, [(Strong Buy 1.0 - 5.0 (Sell)] as on contradiction to last week recommendation of 1.6, which denotes zero variation in recommendations.

Moving Forces Behind (NASDAQ:KERX) On Confident Run! Click Here

Novavax, Inc. (NVAX) declared selection of Cynthia N. Oliver, Ph.D. to the position of Senior VP, Process Development Operations, effective April 8, 2014. Dr. Oliver will be conscientious for all process development activities, with a specific focus on the firm’s RSV F-protein nanoparticle, seasonal influenza and pandemic influenza vaccine candidates.

Novavax, Inc. (NASDAQ:NVAX) [Trend Analysis] plunged -4.70%, closing the day at $3.85, after wavering among $3.65 and $4.09 during the trading session. Its net profit margin in lasted declared quarter was -318.62% as compared to -129.13% in previous year in same year. Its beta value stands at 2.13 times. The stock has a 52-week high price of $6.95 and its 52-week low price was $1.68.

Why (NASDAQ:NVAX) Rallied in Active Trading, Find here

]]>
http://technewsperk.com/how-biotechnology-stocks-becom-bearish-ariad-pharmaceuticals-inc-nasdaqaria-keryx-biopharmaceuticals-nasdaqkerx-novavax-inc-nasdaqnvax/213/feed/ 0
Biotech Industr Wear Red Color- Inovio Pharmaceuticals Inc (NYSEMKT:INO), InterMune Inc (NASDAQ:ITMN), Incyte Corporation (NASDAQ:INCY) http://technewsperk.com/biotech-industr-wear-red-color-inovio-pharmaceuticals-inc-nysemktino-intermune-inc-nasdaqitmn-incyte-corporation-nasdaqincy/214/ http://technewsperk.com/biotech-industr-wear-red-color-inovio-pharmaceuticals-inc-nysemktino-intermune-inc-nasdaqitmn-incyte-corporation-nasdaqincy/214/#comments Mon, 14 Apr 2014 11:02:32 +0000 http://technewsperk.com/?p=214 Inovio Pharmaceuticals, Inc. (INO) released the selection of E.J. Brandreth as VP of Quality. He will be answerable for all quality as well as compliance functions for a firm that is moving forward with numerous late as well as early stage clinical trials and scaling up manufacturing and other operational areas to support its broad pipeline of immunotherapies and DNA vaccines. He aims to Inovio’s Chief Operating Officer Dr. Niranjan Sardesai.

Inovio Pharmaceuticals Inc (NYSEMKT:INO) [Trend Analysis] after opening at $2.88 hit its intraday high price of $2.95 moreover then finished at $2.89 by shares slump -3.67%.  At Wall Street for latest quarter, the consensus average estimates of street for the revenue are $1.28M, at the same time as 4 experts forecast $3.88M revenues for the next three months of 2014. As took noticed on the firm sales growth (year/est), it is calculated -12.00% in Current Qtr. and for next quarter was forecasted 393.60%.

Gets Free Inside Facts on (NYSEMKT:INO)

InterMune (ITMN) recently raised after Boehringer Ingelheim IPF trials hit primary endpoint. Boehringer Ingelheim’s INPULSIS-1 as well as -2 trials for nintedanib as a treatment for idiopathic pulmonary fibrosis, or IPF, showed that nintedanib 150 mg twice daily slowed disease sequence by significantly reducing rate of drop in FVC and was associated with an acceptable side-effect profile, according to an abstract posted to the site of the American Thoracic Society.

InterMune Inc (NASDAQ:ITMN) [Trend Analysis] shares trading performance in last session was noticeable, stocks slumped -2.36% with market capitalization of $2.73B, as outstanding shares was $97.11M. The recommendation trends from street professionals are, stock rated at “buy” by four analysts, while one analyst rates as a “sell” security.

Acts and Reacts in Analytic Report, Finds (NASDAQ:ITMN)

Incyte Corporation (NASDAQ:INCY) plans to release its first quarter results on May 1, 2014 at 7:00AM EDT. It is biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat serious unmet medical needs.

Incyte Corporation (NASDAQ:INCY) [Trend Analysis] reported the fall of -1.87% and closed at $46.25 with the total traded volume of $2.62 million shares. Its market capitalization was $7.66B. The stock owned by the Financial Institutions was 100%. The company’s shares have lost -25.55% in last 30 days and -21.41% in previous three months, compared to a decrease of -6.46% and -2.89% in the Nasdaq during the respective periods.

What are Prospects of NASDAQ:INCY, Find the Free Technical Analysis

]]>
http://technewsperk.com/biotech-industr-wear-red-color-inovio-pharmaceuticals-inc-nysemktino-intermune-inc-nasdaqitmn-incyte-corporation-nasdaqincy/214/feed/ 0
Most Volitle Biotech Stocks- Halozyme Therapeutics, Inc. (NASDAQ:HALO), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Vical Incorporated (NASDAQ:VICL) http://technewsperk.com/most-volitle-biotech-stocks-halozyme-therapeutics-inc-nasdaqhalo-vanda-pharmaceuticals-inc-nasdaqvnda-vical-incorporated-nasdaqvicl/215/ http://technewsperk.com/most-volitle-biotech-stocks-halozyme-therapeutics-inc-nasdaqhalo-vanda-pharmaceuticals-inc-nasdaqvnda-vical-incorporated-nasdaqvicl/215/#comments Mon, 14 Apr 2014 11:02:23 +0000 http://technewsperk.com/?p=215 Halozyme Therapeutics, Inc. (HALO) reported that the U.S. FDA has placed a clinical hold on patient enrollment as well as dosing of PEGPH20 in an ongoing phase II study (Study 202). The study is evaluating PEGPH20 at the same time as a first-line therapy for patients suffering from stage IV metastatic pancreatic cancer.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) [Trend Analysis] plunged -0.93%, closing the day at $7.42 in last regular trading. The firm has market capitalization of $932.67M, and enterprise value of $ 823.41M. It has the price over sales value of $15.57 for the most recent quarter. Corporation has the total of cash of $71.50M as compares to total debt of $49.77M for the most recent quarter with the current ratio of 3.74% for the most recent quarter.

Why Investors Show Confidence on (NASDAQ:HALO)

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) will release its first quarter results on first quarter results on May 5, 2014. The firm is focused on the development and commercialization of products for the treatment of central nervous system disorders.

Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) [Trend Analysis] decreased -6.91% to the trading at $13.06. The firm has 52-week low range of $4.31 and 52-week high price was $19.25. The recommendation trends from street professionals are, stock rated at “buy” by two analysts, while one analyst rates as a “strong buy” security. While the noticeable thing is mean recommendation of this week that stands at 1.7, [(Strong Buy 1.0 - 5.0 (Sell)] as on contradiction to last week recommendation of 1.7, which denotes zero variation in recommendations.

Moving Forces Behind (NASDAQ:VNDA) On Confident Run! Click Here

Vical Incorporated (NASDAQ:VICL) expected to release its first quarter resutls on May 5, 2014. Vical Incorporated and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Vical Incorporated (NASDAQ:VICL) [Trend Analysis] slump -1.69%, closing the day at $1.16, after wavering among $1.14 and $1.25 during the trading session. Its net profit margin in lasted declared quarter was -69.70% as compared to -404.74% in previous year in same year. Its beta value stands at 1.77 times. The stock has a 52-week high price of $4.51 and its 52-week low price was $1.01.

Why (NASDAQ:VICL) Rallied in Active Trading, Find here

 

]]>
http://technewsperk.com/most-volitle-biotech-stocks-halozyme-therapeutics-inc-nasdaqhalo-vanda-pharmaceuticals-inc-nasdaqvnda-vical-incorporated-nasdaqvicl/215/feed/ 0
Biotech Stocks in Concerns- Gilead Sciences, Inc. (NASDAQ:GILD), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) http://technewsperk.com/biotech-stocks-in-concerns-gilead-sciences-inc-nasdaqgild-alexion-pharmaceuticals-inc-nasdaqalxn-acadia-pharmaceuticals-inc-nasdaqacad/212/ http://technewsperk.com/biotech-stocks-in-concerns-gilead-sciences-inc-nasdaqgild-alexion-pharmaceuticals-inc-nasdaqalxn-acadia-pharmaceuticals-inc-nasdaqacad/212/#comments Mon, 14 Apr 2014 11:02:15 +0000 http://technewsperk.com/?p=212 Gilead Sciences Inc. (GILD) has seen a flat track record at what time it comes to present year estimation revisions over the previous few weeks, and the consensus for earnings hasn’t been in a trend either. Executive VP of Research and Development and Chief Scientific Officer, Gilead Sciences, Norbert Bischofberger stated that the patients integrated in these analyses are historically amid the most difficult to cure, and many have had no appropriate treatment options until now.

Gilead Sciences, Inc. (NASDAQ:GILD) [Trend Analysis] after opening at $ 64.19 hit its intraday high price of $68.94 moreover then finished at $66.03 by shares surge 0.84%.  At Wall Street for latest quarter, the consensus average estimates of street for the revenue are $3.75B, at the same time as 21 experts forecast $4.15B revenues for the next three months of 2014. As took noticed on the firm sales growth (year/est), it is calculated 48.10% in Current Qtr. and for next quarter was forecasted 50.10%.

Gets Free Inside Facts on (NASDAQ:GILD)

Alexion Pharmaceuticals, Inc. (ALXN) will report its financial results for the Q1 ended March 31, 2014 on Thursday, April 24, 2014 before the US financial markets open. After the release of the financial results, Alexion management will conduct a conference call and audio web cast on Thursday, April 24, 2014, at 10:00 a.m. Eastern Time (ET).

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) [Trend Analysis] shares trading performance in last session was noticeable, stocks slumped -3.18% with market capitalization of $27.62B, as outstanding shares was $197.83M. The recommendation trends from street professionals are, stock rated at “buy” by 8 analysts, while 7 analysts rates as a “hold” security.

Acts and Reacts in Analytic Report, Finds (NASDAQ:ALXN)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) plans to release its first quarter results on May 5, 2014. Biopharmaceutical firm focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) [Trend Analysis] reported the plunged of -4.99% and closed at $19.04 with the total traded volume of 2.67 million shares. Its market capitalization was $1.87B. The stock owned by the Financial Institutions was 86%. The company’s shares have lost -29.03% in last 30 days and -16.94% in previous three months, compared to a decrease of -6.46% and -2.89% in the Nasdaq during the respective periods.

What are Prospects of NASDAQ:ACAD, Find the Free Technical Analysis

 

]]>
http://technewsperk.com/biotech-stocks-in-concerns-gilead-sciences-inc-nasdaqgild-alexion-pharmaceuticals-inc-nasdaqalxn-acadia-pharmaceuticals-inc-nasdaqacad/212/feed/ 0
Active News Stocks- Stocks Facebook (NASDAQ:FB) Regado Biosciences (NASDAQ:RGDO), Impax Laboratories (NASDAQ:IPXL), Zygo Corp (NASDAQ:ZIGO) http://technewsperk.com/active-news-stocks-stocks-facebook-nasdaqfb-regado-biosciences-nasdaqrgdo-impax-laboratories-nasdaqipxl-zygo-corp-nasdaqzigo/223/ http://technewsperk.com/active-news-stocks-stocks-facebook-nasdaqfb-regado-biosciences-nasdaqrgdo-impax-laboratories-nasdaqipxl-zygo-corp-nasdaqzigo/223/#comments Mon, 14 Apr 2014 11:02:00 +0000 http://technewsperk.com/?p=223 French insurer Axa SA (AXAHY.PK) revealed on Friday that it has teamed up with Facebook Inc. (NASDAQ:FB) to additional develop its digital, social and mobile sphere in France and worldwide. From side to side this partnership, AXA would benefit from Facebook resources, chiefly including innovation & analytics teams to assist in further developing its brand attendance on Facebook, particularly on mobile. In addition, Facebook would analyze AXA’s communication campaigns’ crash on this social network, and its experts would train AXA’s marketing and digital teams.

Stocks of Facebook Inc (NASDAQ:FB) [Trend Analysis] fell -1.06% to close at $58.53 with the total traded volume of 91.45 million shares as compare to its average volume of 68.69 million. Its market capitalization is $149.08 billion. The company’s shares have dropped -16.50% in the last one month and gain 1.02% in the previous three months, compared to a decrease of -7.13% and -4.19% in the NASDAQ during the respective periods.

How Stocks Detain Intentions (NASDAQ:FB)

Regado Biosciences Inc(NASDAQ:RGDO) reported that the pricing of its underwritten public offering of 10M shares of its common stock, offered at a price of $6.00 a share to the public. The gross continues to Regado from this offering are anticipated to be around $60.0M, before deducting underwriting discounts and commissions, and other estimated offering expenses payable by Regado.

Regado Biosciences Inc. (NASDAQ:RGDO) [Trend Analysis] plunged -18.41%, closing the day at $5.85 in last regular trading. The firm has the market capitalization of $148.16 million, enterprise value of $215.64 million. Corporation has the total of cash of $30.69 million as compares to total debt of $4.45 million for the most recent quarter with the current ratio of 4.30 for the most recent quarter.

How (NASDAQ:RGDO) Get Fame, Trend Reports Reveals Fact

Impax Pharmaceuticals, a division of Impax Laboratories Inc (NASDAQ:IPXL), reported that the resubmission of Impax’s New Drug Application or NDA for RYTARY (IPX066) to the U.S. FDA. IPX066 is a patented extended- release capsule formulation of carbidopa and levodopa, an investigational drug for the symptomatic treatment of Parkinson’s disease or PD.

Impax Laboratories Inc (NASDAQ:IPXL) [Trend Analysis] after opening at $24.11 hit its intraday high price of $25.25 moreover then finished at $24.55 by shares advanced 0.70%.  As took noticed on the firm sales growth (year/est), it is calculated -26.80% in Current Qtr. and for next quarter was forecasted 12.20%.

 

Get Free Inside Facts on (NASDAQ:IPXL)

Ametek Inc. (AME) and Zygo Corp. (ZIGO) reported on Friday that they signed a definitive merger contract by which Ametek will buy all of the outstanding shares of common stock of Zygo at a purchase price of $19.25 a share in cash, which represents a premium of 31 percent to Zygo’s closing share price on April 10, 2014. The aggregate enterprise value of the transaction is around $280M, taking into account Zygo’s outstanding equity awards and net cash to be acquired in the transaction.

Zygo Corporation (NASDAQ:ZIGO) [Trend Analysis] gained 32.36%, closing the day at $19.43 in last regular trading while in after hours trading shares moved down -0.41%. Corporation has the total of cash of $90.44 million as compares to zero debt for the most recent quarter with the current ratio of 6.50 for the most recent quarter.

Acts and Reacts in Analytic Report, Finds (NASDAQ:ZIGO)

 

]]>
http://technewsperk.com/active-news-stocks-stocks-facebook-nasdaqfb-regado-biosciences-nasdaqrgdo-impax-laboratories-nasdaqipxl-zygo-corp-nasdaqzigo/223/feed/ 0
Stock in Consideration – UQM Technologies (NYSEMKT:UQM), Voxeljet(NYSE:VJET), Edwards Lifesciences (NYSE:EW), Alcoa (NYSE:AA) http://technewsperk.com/stock-in-consideration-uqm-technologies-nysemktuqm-voxeljetnysevjet-edwards-lifesciences-nyseew-alcoa-nyseaa/224/ http://technewsperk.com/stock-in-consideration-uqm-technologies-nysemktuqm-voxeljetnysevjet-edwards-lifesciences-nyseew-alcoa-nyseaa/224/#comments Mon, 14 Apr 2014 11:01:37 +0000 http://technewsperk.com/?p=224 UQM Technologies, Inc. (UQM) reported that William Rankin would give up work and resign as Board Chairman, effective April 30, 2014. In the meantime, Donald Vanlandingham has been elected as the new Chairman, with effect from May 1, 2014.  Rankin, who joined the firm in 1992, served as Chief Executive from 1999 until his retirement from that position in 2010. In 1996, he was elected to the board, and became Chairman in 2000.  Last session trading was noticeable, UQM Technologies Inc (NYSEMKT:UQM) [Trend Analysis], stocks dropped -1.52% with market capitalization of $97.22 million, as outstanding shares was 37.54 million.

What are Prospects of UQM, Find the Free Technical Analysis

A provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, Voxeljet AG (ADR) (NYSE:VJET) reported that the pricing of its public offering of 3 million American Depositary Shares or “ADSs” at a public offering price of $15.00 per ADS. The offering is expected to close on April 16, 2014, subject to the satisfaction of customary closing conditions.

Voxeljet AG (ADR) (NYSE:VJET) [Trend Analysis] traded at $15.10 after plunging -18.60% with around 5.05 million traded volume in most recent session. Its fifty-two week range was $15.01 – $70.00. The firm has the total cash of $44.28 million as compares to total debt of $7.49 million for the most recent quarter with the current ratio of 5.64 for the most recent quarter.

Moving Forces Behind (NYSE:VJET) On Confident Run! Click Here

Edwards Lifesciences Corp (NYSE:EW) reported on Friday that the U.S. District Court for the District of Delaware has granted a preliminary injunction limiting the sale of Medtronic Inc.’s CoreValve system in the United States.

Edwards Lifesciences Corp (NYSE:EW) [Trend Analysis] shown itself as moving stock, down  -2.05% to close at $24.91 with the overall traded volume of 1.49 million shares. Its total outstanding shares are 107.24 million shares with the market capitalization of $7.83 billion. Its beta value stands at 0.47 times and price to earnings ratio was 21.29%.

Why (NYSE:EW) Rallied in Active Trading, Find here

Fitch Ratings revealed on Friday that it has cut its ratings for Alcoa Inc. (AA) including its Issuer Default Rating as well as senior unsecured debt to ‘BB+’ from ‘BBB-’.  Fitch declared that the downgrade reflects its view that financial leverage will remain above 2.5x on a total debt/EBITDA level and above 3.5x on an FFO adjusted level through 2014. Significant pension contributions will keep FFO adjusted leverage above 3.5 through 2015.

Alcoa Inc’s (NYSE:AA) [Trend Analysis] shares price change percentage of -1.26% to closed at $12.54. It has the revenue of $23.03 billion with the revenue per share of $21.53. Its total outstanding shares are 1.17 billion shares with the market capitalization of $14.69 billion.  Its net profit margin in lasted declared quarter was -3.61% as compared to -9.74% in previous year in same year.

Why Investors Show Confidence on (NYSE:AA)

 

]]>
http://technewsperk.com/stock-in-consideration-uqm-technologies-nysemktuqm-voxeljetnysevjet-edwards-lifesciences-nyseew-alcoa-nyseaa/224/feed/ 0
HBO PPV: PACQUIAO vs BRADLEY LIVE Fight: WatcH Boxing Online Game Saturday Night MGM Grands Las Vegas Nevada http://technewsperk.com/hbo-ppv-pacquiao-vs-bradley-fight/204/ http://technewsperk.com/hbo-ppv-pacquiao-vs-bradley-fight/204/#comments Sat, 12 Apr 2014 14:30:28 +0000 http://technewsperk.com/?p=204 PACQUIAO vs BRADLEY Live FIght: Watch HBO PPV PACQUIAO vs BRADLEY live streaming Boxing Online Game Saturday Night MGM Grands Las Vegas Nevada. Manny Pacquiao vs Timothy Bradley time Preview : Pacquiao conquered the sixth round of the match, entrapping Bradley in the corners of the ring while escaping various successive unreturned punches.

PACQUIAO vs BRADLEY LIVE – Watch Here

During the final round, both fighters seemed to dominate the action. Bradley sent a powerful shot to Pacquiao’s jaw with the match ending in a series of blows from both fighters. Bradley won the last round on all the judges’ scorecards.

Pacquiao actually wishes to achieve a credible win to assist continue his boxing talent. He can make the decision on his own rather than leave it in the hands of a third party through a knockout. He must be in a position to harden up his ageing body while sustaining brutal and unexpected blows.

The real issue here is that Pacquiao fears the fact that Bradley is an upcoming young fighter. He has demonstrated great stability and posed a challenge by taking down Juan Manuel and Ruslan Provodnikov. With his energetic body, relatively swift punches and good defense styles, Bradley is surely going to pose real headache to Pacquiao.

On the other hand, Bradley will not be meeting a very easy Pacquiao. Upon losing to Bradley in 2012, Pac-man was brought down by Marquez. Pacquiao proved really tough when he won against Marquez.

In case Pacquiao can develop aggression and come up with better punching strategies while efficiently making use of his energy, and then he will win the match. Otherwise his boxing career will be brought to a halt.

 

 

 

]]>
http://technewsperk.com/hbo-ppv-pacquiao-vs-bradley-fight/204/feed/ 0
U.S Hot Stock in Consideration – Sony Corp (NYSE:SNE), Boston Scientific (NYSE:BSX), Fastenal (NASDAQ:FAST), JPMorgan Chase & Co (NYSE:JPM) http://technewsperk.com/u-s-hot-stock-in-consideration-sony-corp-nysesne-boston-scientific-nysebsx-fastenal-nasdaqfast-jpmorgan-chase-co-nysejpm/181/ http://technewsperk.com/u-s-hot-stock-in-consideration-sony-corp-nysesne-boston-scientific-nysebsx-fastenal-nasdaqfast-jpmorgan-chase-co-nysejpm/181/#comments Fri, 11 Apr 2014 12:49:23 +0000 http://technewsperk.com/?p=181 Japanese consumer electronics giant Sony Corp. (SNE) to have issued a warning in excess of the risk batteries on its new Vaio personal computers overheating and catching fire and has cautioned its consumers to stop using its Vaio Fit 11A laptop models immediately, according to the Wall Street Journal. Stocks of Sony Corp (ADR) (NYSE:SNE) [Trend Analysis] down -3.56% to close at $18.15 with the total average volume of 2.20 million. Its shares were trading within the range of $18.13 – $18.55, while its opening price was $18.83.

Why (NYSE: SNE) Rallied in Active Trading, Find here

Boston Scientific (BSX) has registered the first patient in a new registry to assess clinical outcomes and the economic value of the Vercise Deep Brain Stimulation System in patients with Parkinson’s disease.   Last session trading was noticeable, Boston Scientific Corporation (NYSE:BSX) [Trend Analysis], stocks dropped -4.51% with market capitalization of $17.11 billion, as outstanding shares was 1.32 million. Recently in a pool of analysts, 12 analysts rates its stocks at “Hold,” 3 analysts rate it at “strong buy” and 7 rate it a “Buy.”

Why Investors Show Confidence on (NYSE:BSX)

Industrial and construction supplies provider Fastenal Company (NASDAQ:FAST) is scheduled to post first quarter results before the opening bell. The firm is anticipated to earn $0.38 a share, marginally higher than the previous year’s $0.37 a share. Revenues are projected to increase to $869.99M from $806.33 million reported a year ago.

Fastenal Company (NASDAQ:FAST) [Trend Analysis] reported the loss of -0.41% and closed at $50.73 with the total average volume of 2.26 million shares. While the noticeable thing is mean recommendation of this week that stands at 2.5, [(Strong Buy 1.0 - 5.0 (Sell)] as on contradiction to last week recommendation of 2.5, which denotes zero variation in recommendations.

Why Intentions Divert, Finds Facts (NASDAQ:FAST)

Financial services giant JPMorgan Chase & Co. (NYSE:JPM) is plans to release Q1 results before the markets open. The earnings of the firm are anticipated to drop to $1.40 a share from $1.59 per share last year, while quarterly revenues are anticipated to decrease to $24.53 billion from the prior year’s $25.85 billion.

JPMorgan Chase & Co. (NYSE:JPM) [Trend Analysis] traded at $57.40 after decreasing -3.16% with around 18.98 million traded volume in most recent session. Its fifty-two week range was $46.05 – $61.48. The firm has the total cash of $974.34 billion as compares to total debt of $641.82 billion for the most recent quarter.

How Stocks Detain Intentions (NYSE:JPM)

]]>
http://technewsperk.com/u-s-hot-stock-in-consideration-sony-corp-nysesne-boston-scientific-nysebsx-fastenal-nasdaqfast-jpmorgan-chase-co-nysejpm/181/feed/ 0
Stocks With Major Movement – Wal-Mart Stores (NYSE:WMT), AbbVie (NYSE:ABBV), Facebook (NASDAQ:FB), Coldwater Creek (NASDAQ:CWTR) http://technewsperk.com/stocks-with-major-movement-wal-mart-stores-nysewmt-abbvie-nyseabbv-facebook-nasdaqfb-coldwater-creek-nasdaqcwtr/180/ http://technewsperk.com/stocks-with-major-movement-wal-mart-stores-nysewmt-abbvie-nyseabbv-facebook-nasdaqfb-coldwater-creek-nasdaqcwtr/180/#comments Fri, 11 Apr 2014 12:47:45 +0000 http://technewsperk.com/?p=180 Wal-Mart Stores, Inc. (WMT) reported that the re-release of Wild Oats’ (OATS) organic foods this month, in a plan to bring down organic food prices. This would enable customers to save as a minimum 25%, compared with other brands. The organic food items will comprise a wide range of categories from salsa and pasta sauce to quinoa and chicken broth.

In last trading session, shares of Wal-Mart Stores, Inc. (NYSE:WMT) [Trend Analysis] down -1.39%, closing the day at $76.89, after wavering among $76.65 and $78.14 during the trading session. Its net profit margin in lasted declared quarter was 3.50% as compared to 3.45% in previous year in same year. Its beta value stands at 0.37 times.

What are Prospects of WMT, Find the Free Technical Analysis

AbbVie Inc (NYSE:ABBV) reported on Friday that it detailed results from its phase III pivotal study, SAPPHIRE-I, would be presented today at the International Liver Congress or ILC 2014 and featured in the ILC press conference.  Results from the essential phase III study, SAPPHIRE-II, were also presented at the congress yesterday.

AbbVie Inc (NYSE:ABBV) [Trend Analysis] reported the loss of -6.48% and closed at $47.35 with the total average volume of 6.06.13 million shares. Its market capitalization is $75.57 billion. The company’s shares have fell -8.33% in the last one month and -6.96% in the previous three months, compared to a decrease of -1.87% and -0.69% in the S&P 500 during the respective periods.

Get Free Inside Facts on (NYSE:ABBV)

Social networking giant Facebook Inc. (FB) reportedly declared on Thursday that the Federal Trade Commission or FTC cleared its acquisition of mobile messaging service WhatsApp in a $19B agreement. In the meantime, the director of the FTC’s Bureau of Consumer Protection notified Facebook and WhatsApp about their obligations to protect the privacy of their users.

Facebook Inc (NASDAQ:FB) [Trend Analysis] lowered -5.21%, closing the day at $59.16 in last regular trading. Corporation has the total of cash of $11.45 billion as compares to total debt of $476.00 million for the most recent quarter with the current ratio of 11.88 for the most recent quarter.

Acts and Reacts in Analytic Report, Finds (NASDAQ:FB)

Women’s clothing and accessories retailer Coldwater Creek Inc. (CWTR) reported on Friday that the firm and all of its U.S. subsidiaries have filed voluntary petitions under Chapter 11 in the U.S. Bankruptcy Court in Wilmington, Delaware.

Coldwater Creek Inc. (NASDAQ:CWTR) [Trend Analysis] after opening at $0.22 hit its intraday high price of $0.23 moreover then finished at $0.190 by shares fell -16.99%.  As took noticed on the firm sales growth (year/est), it is calculated -22.60%in Current Qtr. and for next quarter was forecasted -8.80%.

Moving Forces Behind (NASDAQ:CWTR) On Confident Run! Click Here

]]>
http://technewsperk.com/stocks-with-major-movement-wal-mart-stores-nysewmt-abbvie-nyseabbv-facebook-nasdaqfb-coldwater-creek-nasdaqcwtr/180/feed/ 0